Monday 20 November 2017
Contact US    |    Archive
PR
2 months ago

GSK s Shingrix containing Agenus QS-21 Stimulon® adjuvant receives Unanimous FDA Advisory Committee recommendation for approval

LEXINGTON, Mass., Sept. 13, 2017 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology comp

Read on the original site


Hashtags:   

GSK

 | 

Shingrix

 | 

containing

 | 

Agenus

 | 

Stimulon®

 | 

adjuvant

 | 

receives

 | 

Unanimous

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries